No Data
No Data
Yuchen Asia Vets (688638.SH): 3,925,900 restricted shares will be lifted on July 12th.
On July 4, Gelunhui reported that the total number of stocks issued by Yuchen Asia Vets (688638.SH) was 3,925,866. The date of the stock listing is July 12, 2024.
Siasun Robot&Automation (688638.SH): The medical robot sold is an automated chemical synthesis workstation combined with humans.
Yuchen Asia Vets (Siasun Robot&Automation) stated on its investor platform on June 27 that the medical robot sold by the company is a human-robot combined automated chemical synthesis workstation, which is specifically used for the research and development of new biopharmaceuticals.
Asia Vets (688638.SH) 2023 equity distribution: 0.4 shares will be issued for each share and 0.14 yuan will be distributed.
Asia Vets News APP News, Yuchen Intelligent (688638.SH) released an announcement that the company's 2023 annual equity distribution implemented: cash dividend of 0.14 yuan per share (including tax), capital reserve fund to each shareholder at a ratio of 0.4 shares per share, the record date for equity registration is June 19, 2024, and the ex-dividend (interest) date is June 20, 2024.
Asia Vets (688638.SH): No share buybacks have been implemented yet.
On June 3, Gelunhui announced that as of June 4, 2024, Asia Vets has not yet implemented share repurchases.
Yuchen Intelligence (688638.SH) announced first-quarter results with a net loss of 18.3224 million yuan
According to Zhitong Finance App News, Yuchen Intelligence (688638.SH) released its report for the first quarter of 2024. The company's revenue was 131 million yuan, down 16.84% year on year; net loss attributable to shareholders of listed companies was 18.32,400 yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 2008.27 million yuan; basic loss per share was 0.46 yuan/share.
Yuchen Intelligence (688638.SH): 2023 net profit of 56.024,600 yuan, a year-on-year decrease of 25.91%
Gelonghui, Feb. 25, 丨 Yuchen Intelligence (688638.SH) announced the 2023 annual results report. During the reporting period, the company achieved operating income of 120,64885 million yuan, an increase of 68.97%; net profit attributable to shareholders of listed companies was 56.024,600 yuan, a year-on-year decrease of 25.91%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 419.277 million yuan, a year-on-year decrease of 36.12%.
No Data